{"gene":"ATP7B","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2022,"finding":"Cryo-EM structure of frog ATP7B in a copper-free state revealed that the six N-terminal metal-binding domains interact with both the A and P domains, a ring of negatively charged residues lines the cytoplasmic copper entrance gated by a conserved basic residue, and a network of copper-coordinating ligands in the membrane delineates a stepwise copper transport pathway.","method":"Cryo-electron microscopy structural determination","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure with functional domain analysis","pmids":["35245129"],"is_preprint":false},{"year":2023,"finding":"Cryo-EM structures of human ATP7B in E1 state (apo, copper-bound, and cisplatin-bound forms) showed that the sixth metal-binding domain (MBD6) binds at the cytosolic copper entry site of the transmembrane domain, facilitating copper delivery from MBD6 to the TMD; sulfur-containing residues in the TMD mark the copper transport pathway; comparison with E2-Pi frog ATP7B supported an ATP-driven copper transport model.","method":"Cryo-electron microscopy structural determination with comparative analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 — multiple cryo-EM structures with mechanistic interpretation and comparative analysis","pmids":["37074913"],"is_preprint":false},{"year":2014,"finding":"In response to elevated copper, ATP7B moves from the Golgi to lysosomes, imports copper into lysosomal lumen, and enables lysosomal exocytosis through interaction with p62 subunit of dynactin, allowing lysosome translocation toward the canalicular pole of hepatocytes for copper excretion.","method":"Live imaging, Co-IP, siRNA knockdown, copper transport assays in hepatocytes","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including interaction studies, trafficking assays, and functional copper export measurements","pmids":["24909901"],"is_preprint":false},{"year":1998,"finding":"Mutation of the conserved CPC (Cys-Pro-Cys) motif in the transmembrane domain of ATP7B results in a non-functional protein, demonstrating this motif is essential for copper transport; Wilson disease missense mutations in membrane-spanning segments retain partial copper transport activity as assessed by yeast complementation.","method":"Yeast complementation assay (ccc2 mutant rescue), site-directed mutagenesis","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1 — reconstitution-type functional assay with mutagenesis","pmids":["9837819"],"is_preprint":false},{"year":1998,"finding":"ATP7B protein introduced by adenovirus-mediated gene delivery localizes to the Golgi apparatus in hepatocytes and restores holoceruloplasmin synthesis (copper loading of ceruloplasmin) in the Long-Evans Cinnamon rat Wilson disease model.","method":"Recombinant adenovirus gene delivery, immunofluorescence, subcellular fractionation, Western blot, plasma ceruloplasmin assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — in vivo functional rescue with multiple readouts","pmids":["9430732"],"is_preprint":false},{"year":2007,"finding":"COMMD1 specifically interacts with the amino-terminal region of ATP7B independent of copper levels or ATOX1 expression; four Wilson disease mutations in this region enhance binding to COMMD1 and increase ATP7B degradation rate, indicating COMMD1 regulates ATP7B stability.","method":"GST pull-down, co-immunoprecipitation, immunofluorescence, site-directed mutagenesis, biosynthetic labeling","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus multiple orthogonal methods","pmids":["17919502"],"is_preprint":false},{"year":2011,"finding":"Clusterin and COMMD1 independently interact with ATP7B and down-regulate it via distinct degradation pathways: clusterin facilitates lysosomal degradation of ATP7B, while COMMD1 targets it to the proteasomal pathway; oxidative stress enhances clusterin/ATP7B interaction but not COMMD1/ATP7B interaction.","method":"Co-immunoprecipitation, overexpression/knockdown, pathway inhibitor studies, Western blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP with multiple orthogonal functional validations","pmids":["22130675"],"is_preprint":false},{"year":2000,"finding":"Certain Wilson disease ATP7B variants (Asp765Asn, Leu776Val) retain copper transport activity in yeast but show defective copper-induced subcellular redistribution in mammalian cells; the CPC motif mutant localizes normally but cannot redistribute in response to copper; Arg778Leu is mislocalized to the endoplasmic reticulum.","method":"Yeast complementation assay, transient transfection of CHO cells, triple-label immunofluorescence microscopy","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — combined functional transport assay and localization studies with multiple mutants","pmids":["10942420"],"is_preprint":false},{"year":2007,"finding":"ATP7B trafficking from the TGN is regulated by its copper-translocation cycle: mutation of the phosphorylation domain (DKTGTIT) blocks copper-induced redistribution from the TGN, while mutation of the phosphatase domain (TGE) traps ATP7B at cytosolic vesicular compartments; copper binding to the six N-terminal MBDs or the CPC motif is not essential for trafficking, but copper itself is required.","method":"Site-directed mutagenesis, copper chelation studies, confocal microscopy in mammalian cells","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis of catalytic residues with functional imaging readout","pmids":["16939419"],"is_preprint":false},{"year":2009,"finding":"The N-terminal domain of ATP7B is phosphorylated by an ATP-dependent kinase; copper binding to the N-terminal domain alters its conformation (protecting MBD1-2 and MBD4-5 linkers from proteolysis while exposing MBD2-3 and MBD3-4 regions) and facilitates phosphorylation by 25-30%; mass spectrometry identified the loop connecting MBD3 and MBD4 as the phosphorylation region.","method":"In vitro kinase assay, limited proteolysis, 2D gel electrophoresis, mass spectrometry","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical assay with MS identification of phosphorylation site","pmids":["19405516"],"is_preprint":false},{"year":2001,"finding":"The toxic milk (tx) mouse mutation in Wnd/ATP7B disrupts copper-induced relocalization from the TGN and abrogates copper resistance in CHO cells; wild-type ATP7B and ATP7A (MNK) both reside in the TGN under basal copper but sort to different destinations upon copper elevation; elevated copper causes ATP7B accumulation in large multi-vesicular structures resembling late endosomes.","method":"cDNA transfection in CHO cells, co-localization immunofluorescence, ultrastructural studies, copper resistance assay","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — functional and localization studies with multiple methods","pmids":["11157799"],"is_preprint":false},{"year":2003,"finding":"H1069Q-ATP7B is trapped in the endoplasmic reticulum rather than the TGN in human liver hepatocytes and hepatoma cells; truncated ATP7B mutants show diffuse/clustered cytoplasmic patterns distinct from TGN or ER.","method":"Immunogold electron microscopy of human liver tissue, confocal microscopy of GFP-tagged ATP7B mutants in HuH-7 and HepG2 cells","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 — direct localization in human patient tissue plus cell line validation","pmids":["12557139"],"is_preprint":false},{"year":2009,"finding":"Cisplatin binds to the N-terminal copper-binding domain of ATP7B and stimulates catalytic phosphorylation with EC50 similar to copper; deletion of the first four copper-binding sites abolishes cisplatin-induced phosphorylation; unlike copper, cisplatin does not induce trafficking of ATP7B, nor does it compete with copper in a transport assay, arguing against active cisplatin transport through the copper translocation pathway as the mechanism of resistance.","method":"In vitro phosphorylation assay, competitive copper transport assay, cell trafficking microscopy, N-terminal domain deletion mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical assay plus mutagenesis","pmids":["19141620"],"is_preprint":false},{"year":2013,"finding":"ATP7A and ATP7B mediate ATP-dependent translocation of platinum drugs (cisplatin, carboplatin, oxaliplatin) in a fashion similar to copper, as measured by electrical recordings on microsomal fractions; NMR and ESI-MS showed that platinum drugs bind to the first N-terminal metal-binding domain of ATP7A.","method":"Electrical measurements on solid-supported membranes with recombinant Cu-ATPases, NMR spectroscopy, ESI-MS","journal":"Angewandte Chemie (International ed. in English)","confidence":"High","confidence_rationale":"Tier 1 — reconstituted transport assay plus structural characterization","pmids":["24375922"],"is_preprint":false},{"year":2012,"finding":"Wilson disease ATP7B variants show diverse functional defects: some have complete loss of catalytic and transport activity, others retain phospho-intermediate formation but lose transport activity, and others have partial activity losses; transport-competent variants differ in stability and subcellular localization in mammalian cells.","method":"Baculovirus expression in Sf9 cells, catalytic activity measurement, 64Cu transport into vesicles, GFP-fusion confocal microscopy in mammalian cells","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 1 — direct transport assay with 64Cu plus localization studies for 28 variants","pmids":["22240481"],"is_preprint":false},{"year":2006,"finding":"Glutaredoxin (GRX1) interacts with the N-terminus of both ATP7A and ATP7B in a copper-dependent manner requiring intact MxCxxC metal-binding motifs; the interaction is related to the number of metal-binding domains available, suggesting GRX1 facilitates copper-binding by reducing disulfide bonds or deglutathionylating cysteine residues in the CxxC motifs.","method":"Yeast two-hybrid, co-immunoprecipitation from mammalian cells, site-directed mutagenesis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP plus yeast two-hybrid, single lab","pmids":["16884690"],"is_preprint":false},{"year":2009,"finding":"Renal ATP7B does not traffic from the TGN in response to copper elevation (unlike hepatic ATP7B), appears 2-3 kDa smaller than hepatic ATP7B, suggesting cell-type-specific regulation; this likely explains why renal ATP7B cannot compensate for ATP7A loss in Menkes disease and instead may function in intracellular copper storage.","method":"Subcellular fractionation, immunofluorescence microscopy, mRNA analysis, recombinant expression in renal vs. hepatic cells","journal":"Traffic (Copenhagen, Denmark)","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiments in multiple cell types with functional implications, single lab","pmids":["19416479"],"is_preprint":false},{"year":2017,"finding":"Human ATP7B forms stable dimers in eukaryotic cells; deletion of the four N-terminal metal-binding domains does not disrupt dimerization, indicating the dimer interface involves domains conserved across Cu-ATPases; dimeric structure is retained during trafficking between intracellular compartments; negative-stain electron microscopy provided a low-resolution 3D model showing domain positions and dimer interface.","method":"Co-purification of differentially tagged constructs, negative-stain electron microscopy, single-particle analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical purification plus EM, single lab","pmids":["28842499"],"is_preprint":false},{"year":2019,"finding":"Copper relay through the N-terminus of ATP7B follows a model in which MBD1-3 forms a regulatory unit; copper delivery via Atox1 to this unit promotes release of inhibitory interactions; an intact copper site in either MBD5 or MBD6 is required for copper transport; MBD6 alone can deliver copper to truncated ATP7B lacking all six MBDs, suggesting a docking role for MBD6.","method":"Yeast functional complementation assay with strategic cysteine-to-serine mutations blocking individual MBD copper binding","journal":"Metallomics : integrated biometal science","confidence":"Medium","confidence_rationale":"Tier 1 — yeast reconstitution with systematic mutagenesis, single lab","pmids":["31321400"],"is_preprint":false},{"year":2009,"finding":"Wilson disease mutations reduce ATP7B protein expression without affecting mRNA, with retention of mutant ATP7B in the endoplasmic reticulum; reduced expression is rescued by culturing at 30°C or by pharmacological chaperones 4-phenylbutyrate and curcumin, which partially restore protein expression and localization of multiple ATP7B missense mutants.","method":"Cell-based expression assays, immunofluorescence, copper export functional assay, pharmacological chaperone treatment, homology modeling","journal":"Hepatology (Baltimore, Md.)","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in single lab","pmids":["19937698"],"is_preprint":false},{"year":2020,"finding":"The H1069Q mutation promotes ATP7B interaction with HSP70, accelerating ER degradation of the mutant protein; the HSP70 inhibitor-based drug domperidone rescues trafficking and function of ATP7B-H1069Q by impairing its exposure to the HSP70 proteostatic network.","method":"Proteomics (mass spectrometry-based interactome), co-immunoprecipitation, cell-based trafficking assays, copper export functional assay, pharmacological rescue","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — MS-based interactomics plus Co-IP plus functional rescue, multiple orthogonal methods","pmids":["33288711"],"is_preprint":false},{"year":2004,"finding":"ATP7A and ATP7B sequester cisplatin and carboplatin into vesicular compartments, increasing cellular resistance; vesicles from ATP7B-expressing cells contained more platinum after cisplatin and carboplatin exposure; unlike copper, platinum drugs did not trigger relocalization of ATP7A from perinuclear region.","method":"Engineered cell lines expressing ATP7A or ATP7B, platinum drug cytotoxicity assays, vesicle isolation with platinum measurement, immunofluorescence","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 — isogenic cell lines with functional drug accumulation measurements and localization studies","pmids":["15213293"],"is_preprint":false},{"year":2019,"finding":"COMMD1 modulates copper-responsive ATP7B trafficking through PtdIns(4,5)P2 binding; decreased COMMD1 results in loss of ATP7B from lysosomes and TGN under high copper; COMMD1 overexpression or mutation of its PtdIns(4,5)P2-binding site disrupts ATP7B trafficking itinerary and reduces copper export.","method":"Quantitative colocalization analysis, COMMD1 overexpression/knockdown, COMMD1 PtdIns(4,5)P2-binding mutants, confocal microscopy in HepG2 cells","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — systematic mutagenesis plus quantitative imaging, single lab","pmids":["31515276"],"is_preprint":false},{"year":2016,"finding":"ATP7B is transported from the TGN to the bile canaliculus by basolateral sorting, endocytosis, and microtubule-mediated transcytosis through the subapical compartment; ATP7B trafficking vesicles are not incorporated into lysosomes; copper addition does not cause lysosome relocalization or appearance of lysosome markers at the bile canaliculus.","method":"Confocal microscopy, transcytosis assays, lysosome marker co-localization, microtubule disruption, polarized hepatocyte cell models","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — multiple imaging methods in polarized cells, single lab, conflicting with lysosomal exocytosis model","pmids":["27034138"],"is_preprint":false},{"year":2023,"finding":"In polarized epithelia, ATP7B traverses common recycling endosomes, apical sorting endosomes, and apical recycling endosomes en route to the apical membrane; the AP-1A complex provides directionality and TGN retention for ATP7B, while AP-1B governs copper-independent trafficking of ATP7B; pan-AP-1 knockout disrupts sorting of ATP7B.","method":"Mass spectrometry interactomics, AP-1 isoform-specific knockouts, confocal microscopy in polarized epithelial cells, trafficking assays with Wilson disease mutants","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — MS-based partner identification plus genetic knockout plus functional imaging","pmids":["38032054"],"is_preprint":false},{"year":2021,"finding":"ATP7B contains LC3-interaction regions (LIRs) and directly interacts with LC3B in vitro through a conserved C-terminal LIR3 (W1452, L1455); ATP7B and LC3B colocalize on autophagosome membranes under induced autophagy; ATP7B-deficient HepG2 cells show autophagy deficiency under elevated copper, rescued by heterologous ATP7B expression.","method":"In silico LIR prediction, in vitro binding assay, site-directed mutagenesis of LIR residues, confocal colocalization, CRISPR/Cas9 knockout complementation","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro binding plus mutagenesis plus cell imaging, single lab","pmids":["34831341"],"is_preprint":false},{"year":2003,"finding":"Loss of ATP7B in Atp7b-/- mice reduces dopamine beta-hydroxylase (DBH) protein levels and activity and decreases norepinephrine and epinephrine in adrenal glands, demonstrating that ATP7B deficiency affects copper delivery to cuproenzymes even in tissues (adrenal) that do not normally express ATP7B.","method":"Comparison of Atp7b-/- and wild-type mice, Western blot, catecholamine measurement","journal":"Neurochemical research","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function mouse model with specific biochemical readout","pmids":["12718440"],"is_preprint":false},{"year":2006,"finding":"A hepatocytic isoform of PLZF (lacking the BTB domain) interacts with the C-terminal region of ATP7B; both proteins co-localize in trans-Golgi complexes in HepG2 cells; disruption of PLZF reduces ERK activity, and ATP7B expression enhances ERK kinase activity through its C-terminal region.","method":"Yeast two-hybrid, co-immunoprecipitation, immunostaining, ERK activity assay, Drosophila in vivo transgenic validation","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP plus yeast two-hybrid with functional validation","pmids":["16676348"],"is_preprint":false},{"year":2008,"finding":"Copper-induced translocation of ATP7B from the Golgi to dispersed vesicles occurs independently of COMMD1/Murr1 or Rab7-regulated endosomal trafficking; siRNA depletion of COMMD1 or Rab7 or dominant-negative Rab7 does not impair ATP7B translocation.","method":"Confocal microscopy, RNA interference, dominant-negative Rab7 expression","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 — RNAi epistasis with imaging readout, single lab","pmids":["18974300"],"is_preprint":false},{"year":2022,"finding":"TFEB directly binds to CLEAR sites in the proximal promoter and first intron of ATP7B upon platinum drug exposure, accelerating ATP7B transcription; TFEB suppression inhibits ATP7B expression and increases cisplatin sensitivity in resistant ovarian cancer cells.","method":"ChIP, luciferase reporter assays with ATP7B CLEAR regions, TFEB siRNA knockdown, cisplatin cytotoxicity assay","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus reporter assay plus functional knockdown, single lab","pmids":["35053335"],"is_preprint":false},{"year":2020,"finding":"Co-expression of ATP7B mutants A595T and G1061E (mimicking compound-heterozygous state) reveals inter-mutant interactions that alter intracellular localization and trafficking under both low and high copper conditions, distinct from either mutant expressed alone; regulatory domain mutations (A595T, S1362A, S1426I) reduce Cu-transport without affecting TGN targeting, while ATP-binding domain mutations (G1061E, G1101R) cause ER retention.","method":"Transient transfection, confocal microscopy, 64Cu transport assay, co-expression studies","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — direct transport assay plus localization, multiple mutants including compound-heterozygous state","pmids":["32778786"],"is_preprint":false},{"year":2023,"finding":"Atp7b inactivation in mice disrupts normal morphology and function of choroid plexus during postnatal development, causes reorganization of cytoskeleton and cell-cell contacts, loss of Slc31a1 from the apical membrane, and reduction in microvilli/cilia length and number; this results in transient copper deficit in the brain with catecholamine imbalance and lipidome changes.","method":"Atp7b-/- mouse model, immunofluorescence, proteomics, lipidomics, copper measurement","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function mouse model with multiple biochemical and cell biological readouts","pmids":["36626371"],"is_preprint":false},{"year":2017,"finding":"ATP7B in mouse intestine maintains a copper gradient along the duodenal crypt-villus axis by copper-dependent enlargement of ATP7B-containing vesicles; loss of intestinal ATP7B causes triglyceride-filled vesicle accumulation in enterocytes, mislocalization of apolipoprotein B, and loss of chylomicrons, linking copper regulation by ATP7B to lipid metabolism.","method":"Atp7b-/- mouse model, 3D enteroids, immunohistochemistry, X-ray fluorescence, electron microscopy, fluorescent confocal microscopy","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function mouse model plus organoid system with multiple orthogonal methods","pmids":["28958857"],"is_preprint":false}],"current_model":"ATP7B is a P1B-type copper-transporting ATPase that resides in the trans-Golgi network under basal conditions, where it loads copper into ceruloplasmin and other cuproenzymes; upon elevated intracellular copper, it traffics through vesicular intermediates (including lysosomes) to the apical/canalicular membrane of hepatocytes via an AP-1-regulated, microtubule-dependent pathway involving transcytosis and lysosomal exocytosis, coupling its copper-translocation catalytic cycle (requiring the CPC motif and the DKTGTIT phosphorylation site) to intracellular redistribution; its activity is regulated by kinase-mediated phosphorylation of the MBD3-MBD4 linker and by protein interactions with COMMD1 (proteasomal degradation), clusterin (lysosomal degradation), HSP70 (ER-associated degradation of misfolded mutants), and LC3B (autophagy-mediated copper clearance), while its six N-terminal metal-binding domains form a regulatory unit through which copper delivery by Atox1 to MBD1-3 and subsequent loading of MBD5/MBD6 drives transmembrane copper transport as revealed by cryo-EM structures and systematic mutagenesis."},"narrative":{"teleology":[{"year":1998,"claim":"Establishing that ATP7B is a functional copper transporter requiring the CPC motif and that it localizes to the Golgi where it loads copper onto ceruloplasmin answered the fundamental question of what ATP7B does in the cell.","evidence":"Yeast ccc2Δ complementation with CPC mutants; adenoviral ATP7B delivery restoring holoceruloplasmin in Wilson disease rat model","pmids":["9837819","9430732"],"confidence":"High","gaps":["Structural basis for copper translocation through the membrane not yet resolved","Mechanism of copper entry from cytosol to transmembrane pathway unknown"]},{"year":2001,"claim":"Demonstrating that copper elevation triggers ATP7B redistribution from the TGN to multivesicular structures, and that disease mutations abolish this trafficking, established that regulated subcellular localization is integral to ATP7B function.","evidence":"Immunofluorescence and copper resistance assays in CHO cells expressing wild-type and tx-mutant ATP7B","pmids":["11157799","10942420"],"confidence":"High","gaps":["Destination compartment identity (late endosome vs. lysosome vs. apical membrane) debated","Molecular determinants within ATP7B that control trafficking signals undefined"]},{"year":2003,"claim":"Localizing the common H1069Q mutation to the ER in patient liver tissue revealed that protein misfolding and mistrafficking, not solely loss of catalytic activity, is a major disease mechanism in Wilson disease.","evidence":"Immunogold EM on human liver biopsies; confocal microscopy of GFP-tagged mutants in hepatoma cells","pmids":["12557139"],"confidence":"High","gaps":["Whether ER-retained mutants retain partial transport activity in situ was unknown","Degradation pathway for ER-retained ATP7B not yet identified"]},{"year":2007,"claim":"Showing that the DKTGTIT catalytic phosphorylation and TGE phosphatase motifs govern copper-dependent exit from the TGN established that the catalytic cycle itself drives trafficking, uncoupling it from direct copper binding to MBDs.","evidence":"Site-directed mutagenesis of catalytic domains with confocal imaging of copper-induced redistribution","pmids":["16939419"],"confidence":"High","gaps":["How catalytic turnover is transduced into vesicle budding signals remained unclear","Coat proteins or adaptors mediating TGN exit not identified"]},{"year":2007,"claim":"Identifying COMMD1 as a stability regulator of ATP7B, with disease mutations enhancing COMMD1 binding and accelerating degradation, provided the first mechanism linking Wilson disease variants to altered proteostasis.","evidence":"Reciprocal Co-IP, GST pull-down, biosynthetic labeling of degradation rates in cells expressing WD mutants","pmids":["17919502"],"confidence":"High","gaps":["Whether COMMD1-dependent degradation occurs via ubiquitin–proteasome pathway specifically was not shown","In vivo relevance in hepatocytes not yet tested"]},{"year":2009,"claim":"Mapping kinase-mediated phosphorylation to the MBD3–MBD4 linker and showing copper-induced conformational changes in the N-terminal domain revealed how copper binding is transduced into a regulatory signal for trafficking and catalysis.","evidence":"In vitro kinase assay, limited proteolysis, mass spectrometry identification of phosphosites","pmids":["19405516"],"confidence":"High","gaps":["Identity of the responsible kinase unknown","Functional consequence of phosphorylation on trafficking not directly tested"]},{"year":2011,"claim":"Distinguishing COMMD1-mediated proteasomal degradation from clusterin-mediated lysosomal degradation of ATP7B revealed parallel quality-control pathways regulated by distinct stimuli including oxidative stress.","evidence":"Co-IP with pathway inhibitors (proteasome vs. lysosome), overexpression/knockdown in cell lines","pmids":["22130675"],"confidence":"High","gaps":["Whether both pathways operate simultaneously in hepatocytes in vivo unknown","Ubiquitin ligase mediating proteasomal targeting not identified"]},{"year":2012,"claim":"Systematic functional profiling of 28 Wilson disease variants using direct 64Cu transport assays demonstrated that disease mutations produce a spectrum from complete catalytic loss to normal transport with impaired localization, refining genotype–phenotype understanding.","evidence":"Baculovirus-expressed ATP7B in Sf9 cells, 64Cu vesicular transport, GFP-fusion confocal in mammalian cells","pmids":["22240481"],"confidence":"High","gaps":["In vivo functional rescue by individual variants not tested","Impact of compound heterozygosity on phenotype not addressed"]},{"year":2014,"claim":"Identifying lysosomal exocytosis as a copper excretion pathway — with ATP7B loading copper into lysosomes and p62/dynactin mediating their canalicular translocation — provided a mechanistic framework for hepatic copper disposal.","evidence":"Live imaging, Co-IP of ATP7B/p62-dynactin, siRNA knockdown, copper transport assays in hepatocytes","pmids":["24909901"],"confidence":"High","gaps":["Conflicting data from polarized hepatocyte models suggesting transcytosis rather than lysosomal exocytosis [PMID:27034138]","Whether both pathways coexist in vivo unresolved"]},{"year":2017,"claim":"Demonstrating that ATP7B forms stable dimers and that intestinal ATP7B controls copper-dependent lipid metabolism expanded its functional scope beyond ceruloplasmin loading to systemic metabolic regulation.","evidence":"Co-purification of tagged constructs and negative-stain EM for dimerization; Atp7b−/− mice and 3D enteroids for lipid phenotype","pmids":["28842499","28958857"],"confidence":"Medium","gaps":["Functional significance of dimerization for transport activity unknown","Molecular link between copper transport and apolipoprotein B mislocalization not defined"]},{"year":2019,"claim":"Systematic mutagenesis of individual MBD copper sites established a relay model in which Atox1-to-MBD1–3 copper delivery releases autoinhibition and MBD5/6 copper loading drives transmembrane transport, clarifying the division of labor among six MBDs.","evidence":"Yeast complementation with strategic Cys-to-Ser mutations blocking individual MBD copper binding","pmids":["31321400"],"confidence":"Medium","gaps":["Direct structural visualization of the copper-loaded relay intermediates lacking","Whether all six MBDs are simultaneously occupied in vivo unknown"]},{"year":2020,"claim":"Identifying HSP70 as a triage factor that accelerates ER degradation of H1069Q-ATP7B, and showing that pharmacological HSP70 inhibition rescues mutant trafficking and function, opened a therapeutic avenue for the most common Wilson disease mutation.","evidence":"MS-based interactomics, Co-IP, HSP70 inhibitor domperidone rescue of trafficking and copper export","pmids":["33288711"],"confidence":"High","gaps":["Whether domperidone rescues other ER-retained ATP7B mutants unknown","Long-term efficacy and liver-specific effects not tested in vivo"]},{"year":2022,"claim":"Cryo-EM structures of copper-free frog ATP7B revealed how N-terminal MBDs interact with the actuator/phosphorylation domains and identified a gated cytoplasmic copper entrance lined by charged residues, providing the first atomic framework for the transport cycle.","evidence":"Cryo-EM at near-atomic resolution with domain interaction mapping","pmids":["35245129"],"confidence":"High","gaps":["Only copper-free state resolved; copper-bound conformational changes inferred","Frog ortholog — human-specific features may differ"]},{"year":2023,"claim":"Human ATP7B cryo-EM structures in E1 apo, copper-bound, and cisplatin-bound states confirmed MBD6 docking at the transmembrane copper entry site and delineated the sulfur-coordinated translocation pathway, completing the structural picture across catalytic states.","evidence":"Cryo-EM of human ATP7B in multiple states with comparative analysis to frog E2-Pi structure","pmids":["37074913"],"confidence":"High","gaps":["E2 state of human ATP7B not yet resolved","Structural basis for copper release into the luminal side not defined"]},{"year":2023,"claim":"Identifying AP-1A and AP-1B as mediators of ATP7B directionality in polarized epithelia resolved a long-standing question of how TGN retention and copper-dependent apical sorting are coordinated.","evidence":"MS interactomics, AP-1 isoform-specific knockouts, confocal trafficking in polarized epithelial cells","pmids":["38032054"],"confidence":"High","gaps":["Whether AP-1 regulation applies identically in primary hepatocytes vs. epithelial models untested","Phosphorylation-dependent recognition by AP-1 adaptors not demonstrated"]},{"year":null,"claim":"Key unresolved questions include the identity of the kinase phosphorylating the MBD3–MBD4 linker, the structural basis for copper release into the TGN/vesicle lumen, reconciliation of lysosomal exocytosis versus transcytosis models of hepatic copper excretion, and whether ATP7B dimerization is required for transport activity.","evidence":"","pmids":[],"confidence":"Low","gaps":["Kinase identity unknown","Luminal copper release mechanism not structurally resolved","Lysosomal exocytosis vs. transcytosis debate unresolved","Functional role of dimerization untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,1,3,8,14]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[3,4,14,18]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[9]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[4,7,8,10,11]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[11,19,20]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[2,10,21,32]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[2]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[23,24]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[3,4,14,18]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[2,8,23,24]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[4,26,32]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[8,23,24]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[5,6,20]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[25]}],"complexes":[],"partners":["COMMD1","CLU","HSPA1A","ATOX1","MAP1LC3B","AP1M1","GLRX","DCTN4"],"other_free_text":[]},"mechanistic_narrative":"ATP7B is a P1B-type copper-transporting ATPase that resides in the trans-Golgi network under basal conditions, where it loads copper into cuproenzymes such as ceruloplasmin, and undergoes copper-dependent redistribution to vesicular/canalicular compartments to mediate biliary copper excretion [PMID:9430732, PMID:24909901, PMID:27034138]. Cryo-EM structures reveal that the six N-terminal metal-binding domains (MBDs) interact with the actuator and phosphorylation domains in the copper-free state, while MBD6 docks at the cytosolic entry site of the transmembrane domain to deliver copper through a sulfur-coordinated pathway driven by the ATP-dependent catalytic cycle requiring the CPC motif and DKTGTIT phosphorylation site [PMID:35245129, PMID:37074913, PMID:9837819, PMID:16939419]. Copper relay proceeds via Atox1 delivery to a regulatory MBD1–3 unit that releases autoinhibition, enabling copper loading of MBD5/MBD6 for transmembrane transport, while kinase-mediated phosphorylation of the MBD3–MBD4 linker and interactions with COMMD1 (proteasomal degradation), clusterin (lysosomal degradation), and HSP70 (ER-associated degradation of misfolded mutants) regulate ATP7B stability and trafficking [PMID:31321400, PMID:19405516, PMID:17919502, PMID:22130675, PMID:33288711]. Loss-of-function mutations in ATP7B cause Wilson disease, as demonstrated by ER retention of common variants such as H1069Q and by functional rescue in the Long-Evans Cinnamon rat model [PMID:12557139, PMID:9430732, PMID:22240481]."},"prefetch_data":{"uniprot":{"accession":"P35670","full_name":"Copper-transporting ATPase 2","aliases":["Copper pump 2","Wilson disease-associated protein"],"length_aa":1465,"mass_kda":157.3,"function":"Copper ion transmembrane transporter involved in the export of copper out of the cells. It is involved in copper homeostasis in the liver, where it ensures the efflux of copper from hepatocytes into the bile in response to copper overload","subcellular_location":"Mitochondrion","url":"https://www.uniprot.org/uniprotkb/P35670/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ATP7B","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ATP7B","total_profiled":1310},"omim":[{"mim_id":"620009","title":"KERATODERMA-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KDIDAR","url":"https://www.omim.org/entry/620009"},{"mim_id":"614758","title":"DYNACTIN 4; DCTN4","url":"https://www.omim.org/entry/614758"},{"mim_id":"614482","title":"HUPPKE-BRENDEL SYNDROME; HPBDS","url":"https://www.omim.org/entry/614482"},{"mim_id":"610232","title":"ATPase 13A3; ATP13A3","url":"https://www.omim.org/entry/610232"},{"mim_id":"608552","title":"VPS33B LATE ENDOSOME AND LYSOSOME ASSOCIATED; VPS33B","url":"https://www.omim.org/entry/608552"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Golgi apparatus","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":10.0}],"url":"https://www.proteinatlas.org/search/ATP7B"},"hgnc":{"alias_symbol":[],"prev_symbol":["WND"]},"alphafold":{"accession":"P35670","domains":[{"cath_id":"3.30.70.100","chopping":"59-126","consensus_level":"high","plddt":84.6609,"start":59,"end":126},{"cath_id":"3.30.70.100","chopping":"144-215","consensus_level":"high","plddt":86.3214,"start":144,"end":215},{"cath_id":"3.30.70.100","chopping":"258-326","consensus_level":"high","plddt":83.38,"start":258,"end":326},{"cath_id":"3.30.70.100","chopping":"360-429","consensus_level":"high","plddt":85.424,"start":360,"end":429},{"cath_id":"3.30.70.100","chopping":"499-557","consensus_level":"medium","plddt":77.3698,"start":499,"end":557},{"cath_id":"3.30.70.100","chopping":"567-635","consensus_level":"medium","plddt":83.253,"start":567,"end":635},{"cath_id":"2.70.150.10","chopping":"801-855_868-896","consensus_level":"medium","plddt":83.8381,"start":801,"end":896},{"cath_id":"3.40.1110.10","chopping":"1034-1114_1143-1198","consensus_level":"high","plddt":84.3788,"start":1034,"end":1198}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35670","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35670-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35670-F1-predicted_aligned_error_v6.png","plddt_mean":71.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ATP7B","jax_strain_url":"https://www.jax.org/strain/search?query=ATP7B"},"sequence":{"accession":"P35670","fasta_url":"https://rest.uniprot.org/uniprotkb/P35670.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35670/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35670"}},"corpus_meta":[{"pmid":"17531189","id":"PMC_17531189","title":"Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis.","date":"2007","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/17531189","citation_count":352,"is_preprint":false},{"pmid":"24909901","id":"PMC_24909901","title":"Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis.","date":"2014","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/24909901","citation_count":232,"is_preprint":false},{"pmid":"16791614","id":"PMC_16791614","title":"Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing.","date":"2006","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16791614","citation_count":187,"is_preprint":false},{"pmid":"9430732","id":"PMC_9430732","title":"Restoration of holoceruloplasmin synthesis in LEC rat after infusion of recombinant adenovirus bearing WND cDNA.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9430732","citation_count":135,"is_preprint":false},{"pmid":"9837819","id":"PMC_9837819","title":"Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant?","date":"1998","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9837819","citation_count":126,"is_preprint":false},{"pmid":"17919502","id":"PMC_17919502","title":"Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.","date":"2007","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/17919502","citation_count":125,"is_preprint":false},{"pmid":"10942420","id":"PMC_10942420","title":"Copper-dependent trafficking of Wilson disease mutant ATP7B proteins.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10942420","citation_count":124,"is_preprint":false},{"pmid":"22240481","id":"PMC_22240481","title":"Diverse functional properties of Wilson disease ATP7B variants.","date":"2012","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/22240481","citation_count":122,"is_preprint":false},{"pmid":"15213293","id":"PMC_15213293","title":"Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.","date":"2004","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15213293","citation_count":119,"is_preprint":false},{"pmid":"19470734","id":"PMC_19470734","title":"Therapeutic Targeting of ATP7B in Ovarian Carcinoma.","date":"2009","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/19470734","citation_count":117,"is_preprint":false},{"pmid":"15519648","id":"PMC_15519648","title":"The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis.","date":"2004","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/15519648","citation_count":112,"is_preprint":false},{"pmid":"19937698","id":"PMC_19937698","title":"Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin.","date":"2009","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19937698","citation_count":107,"is_preprint":false},{"pmid":"12557139","id":"PMC_12557139","title":"Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines.","date":"2003","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/12557139","citation_count":100,"is_preprint":false},{"pmid":"18000748","id":"PMC_18000748","title":"Copper-transporting ATPases ATP7A and ATP7B: cousins, not twins.","date":"2007","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/18000748","citation_count":91,"is_preprint":false},{"pmid":"28958857","id":"PMC_28958857","title":"The Function of ATPase Copper Transporter ATP7B in Intestine.","date":"2017","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/28958857","citation_count":89,"is_preprint":false},{"pmid":"15024742","id":"PMC_15024742","title":"Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients.","date":"2004","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15024742","citation_count":86,"is_preprint":false},{"pmid":"27022412","id":"PMC_27022412","title":"Spectrum and Classification of ATP7B Variants in a Large Cohort of Chinese Patients with Wilson's Disease Guides Genetic Diagnosis.","date":"2016","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/27022412","citation_count":80,"is_preprint":false},{"pmid":"9785470","id":"PMC_9785470","title":"ATP7B (WND) protein.","date":"1998","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9785470","citation_count":79,"is_preprint":false},{"pmid":"24375922","id":"PMC_24375922","title":"Translocation of platinum anticancer drugs by human copper ATPases ATP7A and ATP7B.","date":"2013","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/24375922","citation_count":78,"is_preprint":false},{"pmid":"11157799","id":"PMC_11157799","title":"Effect of the toxic milk mutation (tx) on the function and intracellular localization of Wnd, the murine homologue of the Wilson copper ATPase.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11157799","citation_count":74,"is_preprint":false},{"pmid":"35245129","id":"PMC_35245129","title":"Structure of the Wilson disease copper transporter ATP7B.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35245129","citation_count":72,"is_preprint":false},{"pmid":"22130675","id":"PMC_22130675","title":"Clusterin and COMMD1 independently regulate degradation of the mammalian copper ATPases ATP7A and ATP7B.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22130675","citation_count":72,"is_preprint":false},{"pmid":"17268820","id":"PMC_17268820","title":"Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level.","date":"2007","source":"Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17268820","citation_count":68,"is_preprint":false},{"pmid":"12509969","id":"PMC_12509969","title":"Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin.","date":"2003","source":"Oral oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12509969","citation_count":63,"is_preprint":false},{"pmid":"33640437","id":"PMC_33640437","title":"Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease.","date":"2021","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/33640437","citation_count":61,"is_preprint":false},{"pmid":"26207595","id":"PMC_26207595","title":"Geographic distribution of ATP7B mutations in Wilson disease.","date":"2015","source":"Annals of human biology","url":"https://pubmed.ncbi.nlm.nih.gov/26207595","citation_count":61,"is_preprint":false},{"pmid":"14966923","id":"PMC_14966923","title":"Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease.","date":"2004","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/14966923","citation_count":57,"is_preprint":false},{"pmid":"16884690","id":"PMC_16884690","title":"Copper-dependent interaction of glutaredoxin with the N termini of the copper-ATPases (ATP7A and ATP7B) defective in Menkes and Wilson diseases.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16884690","citation_count":53,"is_preprint":false},{"pmid":"19141620","id":"PMC_19141620","title":"Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19141620","citation_count":52,"is_preprint":false},{"pmid":"32248359","id":"PMC_32248359","title":"ATP7B variant penetrance explains differences between genetic and clinical prevalence estimates for Wilson disease.","date":"2020","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32248359","citation_count":52,"is_preprint":false},{"pmid":"12539962","id":"PMC_12539962","title":"Human copper-transporting ATPase ATP7B (the Wilson's disease protein): biochemical properties and regulation.","date":"2002","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/12539962","citation_count":51,"is_preprint":false},{"pmid":"31924743","id":"PMC_31924743","title":"Metabolic dysregulation in the Atp7b-/- Wilson's disease mouse model.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31924743","citation_count":50,"is_preprint":false},{"pmid":"19416479","id":"PMC_19416479","title":"Cell-specific trafficking suggests a new role for renal ATP7B in the intracellular copper storage.","date":"2009","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/19416479","citation_count":50,"is_preprint":false},{"pmid":"16939419","id":"PMC_16939419","title":"Copper binding to the N-terminal metal-binding sites or the CPC motif is not essential for copper-induced trafficking of the human Wilson protein (ATP7B).","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16939419","citation_count":49,"is_preprint":false},{"pmid":"35923305","id":"PMC_35923305","title":"Cuproptosis-Related Gene - SLC31A1, FDX1 and ATP7B - Polymorphisms are Associated with Risk of Lung Cancer.","date":"2022","source":"Pharmacogenomics and personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35923305","citation_count":48,"is_preprint":false},{"pmid":"17587212","id":"PMC_17587212","title":"Identification of novel ATP7B gene mutations and their functional roles in Korean patients with Wilson disease.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17587212","citation_count":48,"is_preprint":false},{"pmid":"22950421","id":"PMC_22950421","title":"Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease.","date":"2013","source":"Rejuvenation research","url":"https://pubmed.ncbi.nlm.nih.gov/22950421","citation_count":46,"is_preprint":false},{"pmid":"11802810","id":"PMC_11802810","title":"Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma.","date":"2002","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/11802810","citation_count":46,"is_preprint":false},{"pmid":"18636185","id":"PMC_18636185","title":"Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.","date":"2008","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/18636185","citation_count":45,"is_preprint":false},{"pmid":"38186308","id":"PMC_38186308","title":"Combination of the cuproptosis inducer disulfiram and anti‑PD‑L1 abolishes NSCLC resistance by ATP7B to regulate the HIF‑1 signaling pathway.","date":"2024","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38186308","citation_count":44,"is_preprint":false},{"pmid":"37074913","id":"PMC_37074913","title":"Structures of the human Wilson disease copper transporter ATP7B.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37074913","citation_count":44,"is_preprint":false},{"pmid":"27499330","id":"PMC_27499330","title":"Non-ceruloplasmin bound copper and ATP7B gene variants in Alzheimer's disease.","date":"2016","source":"Metallomics : integrated biometal science","url":"https://pubmed.ncbi.nlm.nih.gov/27499330","citation_count":43,"is_preprint":false},{"pmid":"27982432","id":"PMC_27982432","title":"Spectrum of ATP7B mutations and genotype-phenotype correlation in large-scale Chinese patients with Wilson Disease.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27982432","citation_count":41,"is_preprint":false},{"pmid":"30230192","id":"PMC_30230192","title":"Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson's disease phenotype.","date":"2018","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/30230192","citation_count":41,"is_preprint":false},{"pmid":"28271598","id":"PMC_28271598","title":"Dynamics of the metal binding domains and regulation of the human copper transporters ATP7B and ATP7A.","date":"2017","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/28271598","citation_count":40,"is_preprint":false},{"pmid":"23904612","id":"PMC_23904612","title":"Independent pathways downstream of the Wnd/DLK MAPKKK regulate synaptic structure, axonal transport, and injury signaling.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23904612","citation_count":35,"is_preprint":false},{"pmid":"19405516","id":"PMC_19405516","title":"The loop connecting metal-binding domains 3 and 4 of ATP7B is a target of a kinase-mediated phosphorylation.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19405516","citation_count":35,"is_preprint":false},{"pmid":"18974300","id":"PMC_18974300","title":"Copper-induced translocation of the Wilson disease protein ATP7B independent of Murr1/COMMD1 and Rab7.","date":"2008","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18974300","citation_count":33,"is_preprint":false},{"pmid":"28842499","id":"PMC_28842499","title":"Human copper transporter ATP7B (Wilson disease protein) forms stable dimers in vitro and in cells.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28842499","citation_count":32,"is_preprint":false},{"pmid":"31790150","id":"PMC_31790150","title":"Copper-dependent ATP7B up-regulation drives the resistance of TMEM16A-overexpressing head-and-neck cancer models to platinum toxicity.","date":"2019","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/31790150","citation_count":32,"is_preprint":false},{"pmid":"20836889","id":"PMC_20836889","title":"Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.","date":"2010","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/20836889","citation_count":31,"is_preprint":false},{"pmid":"28925357","id":"PMC_28925357","title":"Restraint of presynaptic protein levels by Wnd/DLK signaling mediates synaptic defects associated with the kinesin-3 motor Unc-104.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28925357","citation_count":29,"is_preprint":false},{"pmid":"24697742","id":"PMC_24697742","title":"Structural and metabolic changes in Atp7b-/- mouse liver and potential for new interventions in Wilson's disease.","date":"2014","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24697742","citation_count":29,"is_preprint":false},{"pmid":"32778786","id":"PMC_32778786","title":"Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32778786","citation_count":29,"is_preprint":false},{"pmid":"22158007","id":"PMC_22158007","title":"Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease.","date":"2011","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/22158007","citation_count":28,"is_preprint":false},{"pmid":"23235335","id":"PMC_23235335","title":"Mutational analysis of ATP7B in north Chinese patients with Wilson disease.","date":"2012","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23235335","citation_count":28,"is_preprint":false},{"pmid":"27398169","id":"PMC_27398169","title":"Mutational analysis of ATP7B in Chinese Wilson disease patients.","date":"2016","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/27398169","citation_count":27,"is_preprint":false},{"pmid":"36092366","id":"PMC_36092366","title":"Full-length ATP7B reconstituted through protein trans-splicing corrects Wilson disease in mice.","date":"2022","source":"Molecular therapy. Methods & clinical development","url":"https://pubmed.ncbi.nlm.nih.gov/36092366","citation_count":26,"is_preprint":false},{"pmid":"29637721","id":"PMC_29637721","title":"Presumed missense and synonymous mutations in ATP7B gene cause exon skipping in Wilson disease.","date":"2018","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/29637721","citation_count":26,"is_preprint":false},{"pmid":"12372948","id":"PMC_12372948","title":"Expression in mouse kidney of membrane copper transporters Atp7a and Atp7b.","date":"2002","source":"Nephron","url":"https://pubmed.ncbi.nlm.nih.gov/12372948","citation_count":26,"is_preprint":false},{"pmid":"25961917","id":"PMC_25961917","title":"Rho1-Wnd signaling regulates loss-of-cell polarity-induced cell invasion in Drosophila.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25961917","citation_count":25,"is_preprint":false},{"pmid":"9587140","id":"PMC_9587140","title":"Physiologic function of the Wilson disease gene product, ATP7B.","date":"1998","source":"The American journal of clinical nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/9587140","citation_count":25,"is_preprint":false},{"pmid":"12718440","id":"PMC_12718440","title":"A mutation in the ATP7B copper transporter causes reduced dopamine beta-hydroxylase and norepinephrine in mouse adrenal.","date":"2003","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/12718440","citation_count":25,"is_preprint":false},{"pmid":"35053335","id":"PMC_35053335","title":"TFEB Regulates ATP7B Expression to Promote Platinum Chemoresistance in Human Ovarian Cancer Cells.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35053335","citation_count":24,"is_preprint":false},{"pmid":"31515276","id":"PMC_31515276","title":"COMMD1 and PtdIns(4,5)P2 interaction maintain ATP7B copper transporter trafficking fidelity in HepG2 cells.","date":"2019","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/31515276","citation_count":24,"is_preprint":false},{"pmid":"11961729","id":"PMC_11961729","title":"Chances and shortcomins of adenovirus-mediated ATP7B gene transfer in Wilson disease: proof of principle demonstrated in a pilot study with LEC rats.","date":"2002","source":"Zeitschrift fur Gastroenterologie","url":"https://pubmed.ncbi.nlm.nih.gov/11961729","citation_count":24,"is_preprint":false},{"pmid":"32446740","id":"PMC_32446740","title":"Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models.","date":"2020","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/32446740","citation_count":23,"is_preprint":false},{"pmid":"34470610","id":"PMC_34470610","title":"Mutation analysis of the ATP7B gene and genotype-phenotype correlation in Chinese patients with Wilson disease.","date":"2021","source":"BMC gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/34470610","citation_count":22,"is_preprint":false},{"pmid":"31757510","id":"PMC_31757510","title":"Impact of copper in Xenopus laevis liver: Histological damages and atp7b downregulation.","date":"2019","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/31757510","citation_count":22,"is_preprint":false},{"pmid":"34831341","id":"PMC_34831341","title":"Direct Interaction of ATP7B and LC3B Proteins Suggests a Cooperative Role of Copper Transportation and Autophagy.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34831341","citation_count":21,"is_preprint":false},{"pmid":"27992490","id":"PMC_27992490","title":"Intragenic Deletions in ATP7B as an Unusual Molecular Genetics Mechanism of Wilson's Disease Pathogenesis.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27992490","citation_count":21,"is_preprint":false},{"pmid":"38032054","id":"PMC_38032054","title":"Regulation of the apico-basolateral trafficking polarity of the homologous copper-ATPases ATP7A and ATP7B.","date":"2023","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/38032054","citation_count":20,"is_preprint":false},{"pmid":"31321400","id":"PMC_31321400","title":"Copper relay path through the N-terminus of Wilson disease protein, ATP7B.","date":"2019","source":"Metallomics : integrated biometal science","url":"https://pubmed.ncbi.nlm.nih.gov/31321400","citation_count":20,"is_preprint":false},{"pmid":"36626371","id":"PMC_36626371","title":"Atp7b-dependent choroid plexus dysfunction causes transient copper deficit and metabolic changes in the developing mouse brain.","date":"2023","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36626371","citation_count":19,"is_preprint":false},{"pmid":"15154620","id":"PMC_15154620","title":"Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) in human hepatocellular carcinoma.","date":"2004","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15154620","citation_count":18,"is_preprint":false},{"pmid":"12579329","id":"PMC_12579329","title":"Wilson disease protein ATP7B is localized in the late endosomes in a polarized human hepatocyte cell line.","date":"2003","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12579329","citation_count":18,"is_preprint":false},{"pmid":"39581695","id":"PMC_39581695","title":"CircSpna2 attenuates cuproptosis by mediating ubiquitin ligase Keap1 to regulate the Nrf2-Atp7b signalling axis in depression after traumatic brain injury in a mouse model.","date":"2024","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39581695","citation_count":17,"is_preprint":false},{"pmid":"32997714","id":"PMC_32997714","title":"CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32997714","citation_count":17,"is_preprint":false},{"pmid":"28820536","id":"PMC_28820536","title":"Atp7a and Atp7b regulate copper homeostasis in developing male germ cells in mice.","date":"2017","source":"Metallomics : integrated biometal science","url":"https://pubmed.ncbi.nlm.nih.gov/28820536","citation_count":17,"is_preprint":false},{"pmid":"31254371","id":"PMC_31254371","title":"Association of the canine ATP7A and ATP7B with hepatic copper accumulation in Dobermann dogs.","date":"2019","source":"Journal of veterinary internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31254371","citation_count":17,"is_preprint":false},{"pmid":"16676348","id":"PMC_16676348","title":"A new hepatocytic isoform of PLZF lacking the BTB domain interacts with ATP7B, the Wilson disease protein, and positively regulates ERK signal transduction.","date":"2006","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16676348","citation_count":17,"is_preprint":false},{"pmid":"21034864","id":"PMC_21034864","title":"Six novel ATP7B mutations in Thai patients with Wilson disease.","date":"2010","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21034864","citation_count":17,"is_preprint":false},{"pmid":"27034138","id":"PMC_27034138","title":"Basolateral sorting and transcytosis define the Cu+-regulated translocation of ATP7B to the bile canaliculus.","date":"2016","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/27034138","citation_count":17,"is_preprint":false},{"pmid":"36115342","id":"PMC_36115342","title":"Lack of evidence for ribosomal frameshifting in ATP7B mRNA decoding.","date":"2022","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/36115342","citation_count":16,"is_preprint":false},{"pmid":"32155648","id":"PMC_32155648","title":"ATP7B knockout disturbs copper and lipid metabolism in Caco-2 cells.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32155648","citation_count":16,"is_preprint":false},{"pmid":"23333878","id":"PMC_23333878","title":"Mutation analysis of ATP7B gene in Turkish Wilson disease patients: identification of five novel mutations.","date":"2013","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23333878","citation_count":16,"is_preprint":false},{"pmid":"24892424","id":"PMC_24892424","title":"The effect of zinc and D-penicillamine in a stable human hepatoma ATP7B knockout cell line.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24892424","citation_count":16,"is_preprint":false},{"pmid":"22308153","id":"PMC_22308153","title":"Prevalence of ATP7B Gene Mutations in Iranian Patients With Wilson Disease.","date":"2011","source":"Hepatitis monthly","url":"https://pubmed.ncbi.nlm.nih.gov/22308153","citation_count":16,"is_preprint":false},{"pmid":"22966294","id":"PMC_22966294","title":"ATP7B expression is associated with in vitro sensitivity to cisplatin in non-small cell lung cancer.","date":"2010","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/22966294","citation_count":16,"is_preprint":false},{"pmid":"33288711","id":"PMC_33288711","title":"Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33288711","citation_count":16,"is_preprint":false},{"pmid":"26032686","id":"PMC_26032686","title":"Defective roles of ATP7B missense mutations in cellular copper tolerance and copper excretion.","date":"2015","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/26032686","citation_count":15,"is_preprint":false},{"pmid":"15202786","id":"PMC_15202786","title":"Rapid detection of mutations in Wilson disease gene ATP7B by DNA strip technology.","date":"2004","source":"Clinical chemistry and laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15202786","citation_count":15,"is_preprint":false},{"pmid":"31059521","id":"PMC_31059521","title":"Genetic analysis of ATP7B in 102 south Indian families with Wilson disease.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31059521","citation_count":14,"is_preprint":false},{"pmid":"36343861","id":"PMC_36343861","title":"Pathogenicity of Intronic and Synonymous Variants of ATP7B in Wilson Disease.","date":"2022","source":"The Journal of molecular diagnostics : JMD","url":"https://pubmed.ncbi.nlm.nih.gov/36343861","citation_count":14,"is_preprint":false},{"pmid":"37717021","id":"PMC_37717021","title":"ATP7B R778L mutant hepatocytes resist copper toxicity by activating autophagy and inhibiting necroptosis.","date":"2023","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/37717021","citation_count":14,"is_preprint":false},{"pmid":"30702195","id":"PMC_30702195","title":"Complex ATP7B mutation patterns in Wilson disease and evaluation of a yeast model for functional analysis of variants.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/30702195","citation_count":14,"is_preprint":false},{"pmid":"29732486","id":"PMC_29732486","title":"Metallothionein is elevated in liver and duodenum of Atp7b(-/-) mice.","date":"2018","source":"Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29732486","citation_count":14,"is_preprint":false},{"pmid":"22720308","id":"PMC_22720308","title":"The His1069Gln mutation in the ATP7B gene in Romanian patients with Wilson's disease referred to a tertiary gastroenterology center.","date":"2012","source":"Journal of gastrointestinal and liver diseases : JGLD","url":"https://pubmed.ncbi.nlm.nih.gov/22720308","citation_count":14,"is_preprint":false},{"pmid":"23789284","id":"PMC_23789284","title":"Mutational analysis of ATP7B gene and the genotype-phenotype correlation in patients with Wilson's disease in Serbia.","date":"2013","source":"Vojnosanitetski pregled","url":"https://pubmed.ncbi.nlm.nih.gov/23789284","citation_count":13,"is_preprint":false},{"pmid":"27121102","id":"PMC_27121102","title":"miR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression.","date":"2016","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27121102","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48540,"output_tokens":7428,"usd":0.12852},"stage2":{"model":"claude-opus-4-6","input_tokens":11152,"output_tokens":3808,"usd":0.22644},"total_usd":0.35496,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2022,\n      \"finding\": \"Cryo-EM structure of frog ATP7B in a copper-free state revealed that the six N-terminal metal-binding domains interact with both the A and P domains, a ring of negatively charged residues lines the cytoplasmic copper entrance gated by a conserved basic residue, and a network of copper-coordinating ligands in the membrane delineates a stepwise copper transport pathway.\",\n      \"method\": \"Cryo-electron microscopy structural determination\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure with functional domain analysis\",\n      \"pmids\": [\"35245129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structures of human ATP7B in E1 state (apo, copper-bound, and cisplatin-bound forms) showed that the sixth metal-binding domain (MBD6) binds at the cytosolic copper entry site of the transmembrane domain, facilitating copper delivery from MBD6 to the TMD; sulfur-containing residues in the TMD mark the copper transport pathway; comparison with E2-Pi frog ATP7B supported an ATP-driven copper transport model.\",\n      \"method\": \"Cryo-electron microscopy structural determination with comparative analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple cryo-EM structures with mechanistic interpretation and comparative analysis\",\n      \"pmids\": [\"37074913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In response to elevated copper, ATP7B moves from the Golgi to lysosomes, imports copper into lysosomal lumen, and enables lysosomal exocytosis through interaction with p62 subunit of dynactin, allowing lysosome translocation toward the canalicular pole of hepatocytes for copper excretion.\",\n      \"method\": \"Live imaging, Co-IP, siRNA knockdown, copper transport assays in hepatocytes\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including interaction studies, trafficking assays, and functional copper export measurements\",\n      \"pmids\": [\"24909901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Mutation of the conserved CPC (Cys-Pro-Cys) motif in the transmembrane domain of ATP7B results in a non-functional protein, demonstrating this motif is essential for copper transport; Wilson disease missense mutations in membrane-spanning segments retain partial copper transport activity as assessed by yeast complementation.\",\n      \"method\": \"Yeast complementation assay (ccc2 mutant rescue), site-directed mutagenesis\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution-type functional assay with mutagenesis\",\n      \"pmids\": [\"9837819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ATP7B protein introduced by adenovirus-mediated gene delivery localizes to the Golgi apparatus in hepatocytes and restores holoceruloplasmin synthesis (copper loading of ceruloplasmin) in the Long-Evans Cinnamon rat Wilson disease model.\",\n      \"method\": \"Recombinant adenovirus gene delivery, immunofluorescence, subcellular fractionation, Western blot, plasma ceruloplasmin assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo functional rescue with multiple readouts\",\n      \"pmids\": [\"9430732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"COMMD1 specifically interacts with the amino-terminal region of ATP7B independent of copper levels or ATOX1 expression; four Wilson disease mutations in this region enhance binding to COMMD1 and increase ATP7B degradation rate, indicating COMMD1 regulates ATP7B stability.\",\n      \"method\": \"GST pull-down, co-immunoprecipitation, immunofluorescence, site-directed mutagenesis, biosynthetic labeling\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus multiple orthogonal methods\",\n      \"pmids\": [\"17919502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Clusterin and COMMD1 independently interact with ATP7B and down-regulate it via distinct degradation pathways: clusterin facilitates lysosomal degradation of ATP7B, while COMMD1 targets it to the proteasomal pathway; oxidative stress enhances clusterin/ATP7B interaction but not COMMD1/ATP7B interaction.\",\n      \"method\": \"Co-immunoprecipitation, overexpression/knockdown, pathway inhibitor studies, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with multiple orthogonal functional validations\",\n      \"pmids\": [\"22130675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Certain Wilson disease ATP7B variants (Asp765Asn, Leu776Val) retain copper transport activity in yeast but show defective copper-induced subcellular redistribution in mammalian cells; the CPC motif mutant localizes normally but cannot redistribute in response to copper; Arg778Leu is mislocalized to the endoplasmic reticulum.\",\n      \"method\": \"Yeast complementation assay, transient transfection of CHO cells, triple-label immunofluorescence microscopy\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — combined functional transport assay and localization studies with multiple mutants\",\n      \"pmids\": [\"10942420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ATP7B trafficking from the TGN is regulated by its copper-translocation cycle: mutation of the phosphorylation domain (DKTGTIT) blocks copper-induced redistribution from the TGN, while mutation of the phosphatase domain (TGE) traps ATP7B at cytosolic vesicular compartments; copper binding to the six N-terminal MBDs or the CPC motif is not essential for trafficking, but copper itself is required.\",\n      \"method\": \"Site-directed mutagenesis, copper chelation studies, confocal microscopy in mammalian cells\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis of catalytic residues with functional imaging readout\",\n      \"pmids\": [\"16939419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The N-terminal domain of ATP7B is phosphorylated by an ATP-dependent kinase; copper binding to the N-terminal domain alters its conformation (protecting MBD1-2 and MBD4-5 linkers from proteolysis while exposing MBD2-3 and MBD3-4 regions) and facilitates phosphorylation by 25-30%; mass spectrometry identified the loop connecting MBD3 and MBD4 as the phosphorylation region.\",\n      \"method\": \"In vitro kinase assay, limited proteolysis, 2D gel electrophoresis, mass spectrometry\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical assay with MS identification of phosphorylation site\",\n      \"pmids\": [\"19405516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The toxic milk (tx) mouse mutation in Wnd/ATP7B disrupts copper-induced relocalization from the TGN and abrogates copper resistance in CHO cells; wild-type ATP7B and ATP7A (MNK) both reside in the TGN under basal copper but sort to different destinations upon copper elevation; elevated copper causes ATP7B accumulation in large multi-vesicular structures resembling late endosomes.\",\n      \"method\": \"cDNA transfection in CHO cells, co-localization immunofluorescence, ultrastructural studies, copper resistance assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional and localization studies with multiple methods\",\n      \"pmids\": [\"11157799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"H1069Q-ATP7B is trapped in the endoplasmic reticulum rather than the TGN in human liver hepatocytes and hepatoma cells; truncated ATP7B mutants show diffuse/clustered cytoplasmic patterns distinct from TGN or ER.\",\n      \"method\": \"Immunogold electron microscopy of human liver tissue, confocal microscopy of GFP-tagged ATP7B mutants in HuH-7 and HepG2 cells\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization in human patient tissue plus cell line validation\",\n      \"pmids\": [\"12557139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cisplatin binds to the N-terminal copper-binding domain of ATP7B and stimulates catalytic phosphorylation with EC50 similar to copper; deletion of the first four copper-binding sites abolishes cisplatin-induced phosphorylation; unlike copper, cisplatin does not induce trafficking of ATP7B, nor does it compete with copper in a transport assay, arguing against active cisplatin transport through the copper translocation pathway as the mechanism of resistance.\",\n      \"method\": \"In vitro phosphorylation assay, competitive copper transport assay, cell trafficking microscopy, N-terminal domain deletion mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical assay plus mutagenesis\",\n      \"pmids\": [\"19141620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ATP7A and ATP7B mediate ATP-dependent translocation of platinum drugs (cisplatin, carboplatin, oxaliplatin) in a fashion similar to copper, as measured by electrical recordings on microsomal fractions; NMR and ESI-MS showed that platinum drugs bind to the first N-terminal metal-binding domain of ATP7A.\",\n      \"method\": \"Electrical measurements on solid-supported membranes with recombinant Cu-ATPases, NMR spectroscopy, ESI-MS\",\n      \"journal\": \"Angewandte Chemie (International ed. in English)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted transport assay plus structural characterization\",\n      \"pmids\": [\"24375922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Wilson disease ATP7B variants show diverse functional defects: some have complete loss of catalytic and transport activity, others retain phospho-intermediate formation but lose transport activity, and others have partial activity losses; transport-competent variants differ in stability and subcellular localization in mammalian cells.\",\n      \"method\": \"Baculovirus expression in Sf9 cells, catalytic activity measurement, 64Cu transport into vesicles, GFP-fusion confocal microscopy in mammalian cells\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct transport assay with 64Cu plus localization studies for 28 variants\",\n      \"pmids\": [\"22240481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Glutaredoxin (GRX1) interacts with the N-terminus of both ATP7A and ATP7B in a copper-dependent manner requiring intact MxCxxC metal-binding motifs; the interaction is related to the number of metal-binding domains available, suggesting GRX1 facilitates copper-binding by reducing disulfide bonds or deglutathionylating cysteine residues in the CxxC motifs.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation from mammalian cells, site-directed mutagenesis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP plus yeast two-hybrid, single lab\",\n      \"pmids\": [\"16884690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Renal ATP7B does not traffic from the TGN in response to copper elevation (unlike hepatic ATP7B), appears 2-3 kDa smaller than hepatic ATP7B, suggesting cell-type-specific regulation; this likely explains why renal ATP7B cannot compensate for ATP7A loss in Menkes disease and instead may function in intracellular copper storage.\",\n      \"method\": \"Subcellular fractionation, immunofluorescence microscopy, mRNA analysis, recombinant expression in renal vs. hepatic cells\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiments in multiple cell types with functional implications, single lab\",\n      \"pmids\": [\"19416479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Human ATP7B forms stable dimers in eukaryotic cells; deletion of the four N-terminal metal-binding domains does not disrupt dimerization, indicating the dimer interface involves domains conserved across Cu-ATPases; dimeric structure is retained during trafficking between intracellular compartments; negative-stain electron microscopy provided a low-resolution 3D model showing domain positions and dimer interface.\",\n      \"method\": \"Co-purification of differentially tagged constructs, negative-stain electron microscopy, single-particle analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical purification plus EM, single lab\",\n      \"pmids\": [\"28842499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Copper relay through the N-terminus of ATP7B follows a model in which MBD1-3 forms a regulatory unit; copper delivery via Atox1 to this unit promotes release of inhibitory interactions; an intact copper site in either MBD5 or MBD6 is required for copper transport; MBD6 alone can deliver copper to truncated ATP7B lacking all six MBDs, suggesting a docking role for MBD6.\",\n      \"method\": \"Yeast functional complementation assay with strategic cysteine-to-serine mutations blocking individual MBD copper binding\",\n      \"journal\": \"Metallomics : integrated biometal science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — yeast reconstitution with systematic mutagenesis, single lab\",\n      \"pmids\": [\"31321400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Wilson disease mutations reduce ATP7B protein expression without affecting mRNA, with retention of mutant ATP7B in the endoplasmic reticulum; reduced expression is rescued by culturing at 30°C or by pharmacological chaperones 4-phenylbutyrate and curcumin, which partially restore protein expression and localization of multiple ATP7B missense mutants.\",\n      \"method\": \"Cell-based expression assays, immunofluorescence, copper export functional assay, pharmacological chaperone treatment, homology modeling\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in single lab\",\n      \"pmids\": [\"19937698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The H1069Q mutation promotes ATP7B interaction with HSP70, accelerating ER degradation of the mutant protein; the HSP70 inhibitor-based drug domperidone rescues trafficking and function of ATP7B-H1069Q by impairing its exposure to the HSP70 proteostatic network.\",\n      \"method\": \"Proteomics (mass spectrometry-based interactome), co-immunoprecipitation, cell-based trafficking assays, copper export functional assay, pharmacological rescue\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS-based interactomics plus Co-IP plus functional rescue, multiple orthogonal methods\",\n      \"pmids\": [\"33288711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ATP7A and ATP7B sequester cisplatin and carboplatin into vesicular compartments, increasing cellular resistance; vesicles from ATP7B-expressing cells contained more platinum after cisplatin and carboplatin exposure; unlike copper, platinum drugs did not trigger relocalization of ATP7A from perinuclear region.\",\n      \"method\": \"Engineered cell lines expressing ATP7A or ATP7B, platinum drug cytotoxicity assays, vesicle isolation with platinum measurement, immunofluorescence\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — isogenic cell lines with functional drug accumulation measurements and localization studies\",\n      \"pmids\": [\"15213293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"COMMD1 modulates copper-responsive ATP7B trafficking through PtdIns(4,5)P2 binding; decreased COMMD1 results in loss of ATP7B from lysosomes and TGN under high copper; COMMD1 overexpression or mutation of its PtdIns(4,5)P2-binding site disrupts ATP7B trafficking itinerary and reduces copper export.\",\n      \"method\": \"Quantitative colocalization analysis, COMMD1 overexpression/knockdown, COMMD1 PtdIns(4,5)P2-binding mutants, confocal microscopy in HepG2 cells\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic mutagenesis plus quantitative imaging, single lab\",\n      \"pmids\": [\"31515276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ATP7B is transported from the TGN to the bile canaliculus by basolateral sorting, endocytosis, and microtubule-mediated transcytosis through the subapical compartment; ATP7B trafficking vesicles are not incorporated into lysosomes; copper addition does not cause lysosome relocalization or appearance of lysosome markers at the bile canaliculus.\",\n      \"method\": \"Confocal microscopy, transcytosis assays, lysosome marker co-localization, microtubule disruption, polarized hepatocyte cell models\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple imaging methods in polarized cells, single lab, conflicting with lysosomal exocytosis model\",\n      \"pmids\": [\"27034138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In polarized epithelia, ATP7B traverses common recycling endosomes, apical sorting endosomes, and apical recycling endosomes en route to the apical membrane; the AP-1A complex provides directionality and TGN retention for ATP7B, while AP-1B governs copper-independent trafficking of ATP7B; pan-AP-1 knockout disrupts sorting of ATP7B.\",\n      \"method\": \"Mass spectrometry interactomics, AP-1 isoform-specific knockouts, confocal microscopy in polarized epithelial cells, trafficking assays with Wilson disease mutants\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS-based partner identification plus genetic knockout plus functional imaging\",\n      \"pmids\": [\"38032054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ATP7B contains LC3-interaction regions (LIRs) and directly interacts with LC3B in vitro through a conserved C-terminal LIR3 (W1452, L1455); ATP7B and LC3B colocalize on autophagosome membranes under induced autophagy; ATP7B-deficient HepG2 cells show autophagy deficiency under elevated copper, rescued by heterologous ATP7B expression.\",\n      \"method\": \"In silico LIR prediction, in vitro binding assay, site-directed mutagenesis of LIR residues, confocal colocalization, CRISPR/Cas9 knockout complementation\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro binding plus mutagenesis plus cell imaging, single lab\",\n      \"pmids\": [\"34831341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Loss of ATP7B in Atp7b-/- mice reduces dopamine beta-hydroxylase (DBH) protein levels and activity and decreases norepinephrine and epinephrine in adrenal glands, demonstrating that ATP7B deficiency affects copper delivery to cuproenzymes even in tissues (adrenal) that do not normally express ATP7B.\",\n      \"method\": \"Comparison of Atp7b-/- and wild-type mice, Western blot, catecholamine measurement\",\n      \"journal\": \"Neurochemical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function mouse model with specific biochemical readout\",\n      \"pmids\": [\"12718440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A hepatocytic isoform of PLZF (lacking the BTB domain) interacts with the C-terminal region of ATP7B; both proteins co-localize in trans-Golgi complexes in HepG2 cells; disruption of PLZF reduces ERK activity, and ATP7B expression enhances ERK kinase activity through its C-terminal region.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, immunostaining, ERK activity assay, Drosophila in vivo transgenic validation\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP plus yeast two-hybrid with functional validation\",\n      \"pmids\": [\"16676348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Copper-induced translocation of ATP7B from the Golgi to dispersed vesicles occurs independently of COMMD1/Murr1 or Rab7-regulated endosomal trafficking; siRNA depletion of COMMD1 or Rab7 or dominant-negative Rab7 does not impair ATP7B translocation.\",\n      \"method\": \"Confocal microscopy, RNA interference, dominant-negative Rab7 expression\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNAi epistasis with imaging readout, single lab\",\n      \"pmids\": [\"18974300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TFEB directly binds to CLEAR sites in the proximal promoter and first intron of ATP7B upon platinum drug exposure, accelerating ATP7B transcription; TFEB suppression inhibits ATP7B expression and increases cisplatin sensitivity in resistant ovarian cancer cells.\",\n      \"method\": \"ChIP, luciferase reporter assays with ATP7B CLEAR regions, TFEB siRNA knockdown, cisplatin cytotoxicity assay\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus reporter assay plus functional knockdown, single lab\",\n      \"pmids\": [\"35053335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Co-expression of ATP7B mutants A595T and G1061E (mimicking compound-heterozygous state) reveals inter-mutant interactions that alter intracellular localization and trafficking under both low and high copper conditions, distinct from either mutant expressed alone; regulatory domain mutations (A595T, S1362A, S1426I) reduce Cu-transport without affecting TGN targeting, while ATP-binding domain mutations (G1061E, G1101R) cause ER retention.\",\n      \"method\": \"Transient transfection, confocal microscopy, 64Cu transport assay, co-expression studies\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct transport assay plus localization, multiple mutants including compound-heterozygous state\",\n      \"pmids\": [\"32778786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Atp7b inactivation in mice disrupts normal morphology and function of choroid plexus during postnatal development, causes reorganization of cytoskeleton and cell-cell contacts, loss of Slc31a1 from the apical membrane, and reduction in microvilli/cilia length and number; this results in transient copper deficit in the brain with catecholamine imbalance and lipidome changes.\",\n      \"method\": \"Atp7b-/- mouse model, immunofluorescence, proteomics, lipidomics, copper measurement\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function mouse model with multiple biochemical and cell biological readouts\",\n      \"pmids\": [\"36626371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ATP7B in mouse intestine maintains a copper gradient along the duodenal crypt-villus axis by copper-dependent enlargement of ATP7B-containing vesicles; loss of intestinal ATP7B causes triglyceride-filled vesicle accumulation in enterocytes, mislocalization of apolipoprotein B, and loss of chylomicrons, linking copper regulation by ATP7B to lipid metabolism.\",\n      \"method\": \"Atp7b-/- mouse model, 3D enteroids, immunohistochemistry, X-ray fluorescence, electron microscopy, fluorescent confocal microscopy\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function mouse model plus organoid system with multiple orthogonal methods\",\n      \"pmids\": [\"28958857\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ATP7B is a P1B-type copper-transporting ATPase that resides in the trans-Golgi network under basal conditions, where it loads copper into ceruloplasmin and other cuproenzymes; upon elevated intracellular copper, it traffics through vesicular intermediates (including lysosomes) to the apical/canalicular membrane of hepatocytes via an AP-1-regulated, microtubule-dependent pathway involving transcytosis and lysosomal exocytosis, coupling its copper-translocation catalytic cycle (requiring the CPC motif and the DKTGTIT phosphorylation site) to intracellular redistribution; its activity is regulated by kinase-mediated phosphorylation of the MBD3-MBD4 linker and by protein interactions with COMMD1 (proteasomal degradation), clusterin (lysosomal degradation), HSP70 (ER-associated degradation of misfolded mutants), and LC3B (autophagy-mediated copper clearance), while its six N-terminal metal-binding domains form a regulatory unit through which copper delivery by Atox1 to MBD1-3 and subsequent loading of MBD5/MBD6 drives transmembrane copper transport as revealed by cryo-EM structures and systematic mutagenesis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ATP7B is a P1B-type copper-transporting ATPase that resides in the trans-Golgi network under basal conditions, where it loads copper into cuproenzymes such as ceruloplasmin, and undergoes copper-dependent redistribution to vesicular/canalicular compartments to mediate biliary copper excretion [PMID:9430732, PMID:24909901, PMID:27034138]. Cryo-EM structures reveal that the six N-terminal metal-binding domains (MBDs) interact with the actuator and phosphorylation domains in the copper-free state, while MBD6 docks at the cytosolic entry site of the transmembrane domain to deliver copper through a sulfur-coordinated pathway driven by the ATP-dependent catalytic cycle requiring the CPC motif and DKTGTIT phosphorylation site [PMID:35245129, PMID:37074913, PMID:9837819, PMID:16939419]. Copper relay proceeds via Atox1 delivery to a regulatory MBD1–3 unit that releases autoinhibition, enabling copper loading of MBD5/MBD6 for transmembrane transport, while kinase-mediated phosphorylation of the MBD3–MBD4 linker and interactions with COMMD1 (proteasomal degradation), clusterin (lysosomal degradation), and HSP70 (ER-associated degradation of misfolded mutants) regulate ATP7B stability and trafficking [PMID:31321400, PMID:19405516, PMID:17919502, PMID:22130675, PMID:33288711]. Loss-of-function mutations in ATP7B cause Wilson disease, as demonstrated by ER retention of common variants such as H1069Q and by functional rescue in the Long-Evans Cinnamon rat model [PMID:12557139, PMID:9430732, PMID:22240481].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing that ATP7B is a functional copper transporter requiring the CPC motif and that it localizes to the Golgi where it loads copper onto ceruloplasmin answered the fundamental question of what ATP7B does in the cell.\",\n      \"evidence\": \"Yeast ccc2Δ complementation with CPC mutants; adenoviral ATP7B delivery restoring holoceruloplasmin in Wilson disease rat model\",\n      \"pmids\": [\"9837819\", \"9430732\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for copper translocation through the membrane not yet resolved\", \"Mechanism of copper entry from cytosol to transmembrane pathway unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrating that copper elevation triggers ATP7B redistribution from the TGN to multivesicular structures, and that disease mutations abolish this trafficking, established that regulated subcellular localization is integral to ATP7B function.\",\n      \"evidence\": \"Immunofluorescence and copper resistance assays in CHO cells expressing wild-type and tx-mutant ATP7B\",\n      \"pmids\": [\"11157799\", \"10942420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Destination compartment identity (late endosome vs. lysosome vs. apical membrane) debated\", \"Molecular determinants within ATP7B that control trafficking signals undefined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Localizing the common H1069Q mutation to the ER in patient liver tissue revealed that protein misfolding and mistrafficking, not solely loss of catalytic activity, is a major disease mechanism in Wilson disease.\",\n      \"evidence\": \"Immunogold EM on human liver biopsies; confocal microscopy of GFP-tagged mutants in hepatoma cells\",\n      \"pmids\": [\"12557139\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ER-retained mutants retain partial transport activity in situ was unknown\", \"Degradation pathway for ER-retained ATP7B not yet identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showing that the DKTGTIT catalytic phosphorylation and TGE phosphatase motifs govern copper-dependent exit from the TGN established that the catalytic cycle itself drives trafficking, uncoupling it from direct copper binding to MBDs.\",\n      \"evidence\": \"Site-directed mutagenesis of catalytic domains with confocal imaging of copper-induced redistribution\",\n      \"pmids\": [\"16939419\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How catalytic turnover is transduced into vesicle budding signals remained unclear\", \"Coat proteins or adaptors mediating TGN exit not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identifying COMMD1 as a stability regulator of ATP7B, with disease mutations enhancing COMMD1 binding and accelerating degradation, provided the first mechanism linking Wilson disease variants to altered proteostasis.\",\n      \"evidence\": \"Reciprocal Co-IP, GST pull-down, biosynthetic labeling of degradation rates in cells expressing WD mutants\",\n      \"pmids\": [\"17919502\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether COMMD1-dependent degradation occurs via ubiquitin–proteasome pathway specifically was not shown\", \"In vivo relevance in hepatocytes not yet tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Mapping kinase-mediated phosphorylation to the MBD3–MBD4 linker and showing copper-induced conformational changes in the N-terminal domain revealed how copper binding is transduced into a regulatory signal for trafficking and catalysis.\",\n      \"evidence\": \"In vitro kinase assay, limited proteolysis, mass spectrometry identification of phosphosites\",\n      \"pmids\": [\"19405516\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the responsible kinase unknown\", \"Functional consequence of phosphorylation on trafficking not directly tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Distinguishing COMMD1-mediated proteasomal degradation from clusterin-mediated lysosomal degradation of ATP7B revealed parallel quality-control pathways regulated by distinct stimuli including oxidative stress.\",\n      \"evidence\": \"Co-IP with pathway inhibitors (proteasome vs. lysosome), overexpression/knockdown in cell lines\",\n      \"pmids\": [\"22130675\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether both pathways operate simultaneously in hepatocytes in vivo unknown\", \"Ubiquitin ligase mediating proteasomal targeting not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Systematic functional profiling of 28 Wilson disease variants using direct 64Cu transport assays demonstrated that disease mutations produce a spectrum from complete catalytic loss to normal transport with impaired localization, refining genotype–phenotype understanding.\",\n      \"evidence\": \"Baculovirus-expressed ATP7B in Sf9 cells, 64Cu vesicular transport, GFP-fusion confocal in mammalian cells\",\n      \"pmids\": [\"22240481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo functional rescue by individual variants not tested\", \"Impact of compound heterozygosity on phenotype not addressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identifying lysosomal exocytosis as a copper excretion pathway — with ATP7B loading copper into lysosomes and p62/dynactin mediating their canalicular translocation — provided a mechanistic framework for hepatic copper disposal.\",\n      \"evidence\": \"Live imaging, Co-IP of ATP7B/p62-dynactin, siRNA knockdown, copper transport assays in hepatocytes\",\n      \"pmids\": [\"24909901\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conflicting data from polarized hepatocyte models suggesting transcytosis rather than lysosomal exocytosis [PMID:27034138]\", \"Whether both pathways coexist in vivo unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating that ATP7B forms stable dimers and that intestinal ATP7B controls copper-dependent lipid metabolism expanded its functional scope beyond ceruloplasmin loading to systemic metabolic regulation.\",\n      \"evidence\": \"Co-purification of tagged constructs and negative-stain EM for dimerization; Atp7b−/− mice and 3D enteroids for lipid phenotype\",\n      \"pmids\": [\"28842499\", \"28958857\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional significance of dimerization for transport activity unknown\", \"Molecular link between copper transport and apolipoprotein B mislocalization not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Systematic mutagenesis of individual MBD copper sites established a relay model in which Atox1-to-MBD1–3 copper delivery releases autoinhibition and MBD5/6 copper loading drives transmembrane transport, clarifying the division of labor among six MBDs.\",\n      \"evidence\": \"Yeast complementation with strategic Cys-to-Ser mutations blocking individual MBD copper binding\",\n      \"pmids\": [\"31321400\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct structural visualization of the copper-loaded relay intermediates lacking\", \"Whether all six MBDs are simultaneously occupied in vivo unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identifying HSP70 as a triage factor that accelerates ER degradation of H1069Q-ATP7B, and showing that pharmacological HSP70 inhibition rescues mutant trafficking and function, opened a therapeutic avenue for the most common Wilson disease mutation.\",\n      \"evidence\": \"MS-based interactomics, Co-IP, HSP70 inhibitor domperidone rescue of trafficking and copper export\",\n      \"pmids\": [\"33288711\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether domperidone rescues other ER-retained ATP7B mutants unknown\", \"Long-term efficacy and liver-specific effects not tested in vivo\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Cryo-EM structures of copper-free frog ATP7B revealed how N-terminal MBDs interact with the actuator/phosphorylation domains and identified a gated cytoplasmic copper entrance lined by charged residues, providing the first atomic framework for the transport cycle.\",\n      \"evidence\": \"Cryo-EM at near-atomic resolution with domain interaction mapping\",\n      \"pmids\": [\"35245129\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Only copper-free state resolved; copper-bound conformational changes inferred\", \"Frog ortholog — human-specific features may differ\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Human ATP7B cryo-EM structures in E1 apo, copper-bound, and cisplatin-bound states confirmed MBD6 docking at the transmembrane copper entry site and delineated the sulfur-coordinated translocation pathway, completing the structural picture across catalytic states.\",\n      \"evidence\": \"Cryo-EM of human ATP7B in multiple states with comparative analysis to frog E2-Pi structure\",\n      \"pmids\": [\"37074913\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E2 state of human ATP7B not yet resolved\", \"Structural basis for copper release into the luminal side not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identifying AP-1A and AP-1B as mediators of ATP7B directionality in polarized epithelia resolved a long-standing question of how TGN retention and copper-dependent apical sorting are coordinated.\",\n      \"evidence\": \"MS interactomics, AP-1 isoform-specific knockouts, confocal trafficking in polarized epithelial cells\",\n      \"pmids\": [\"38032054\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether AP-1 regulation applies identically in primary hepatocytes vs. epithelial models untested\", \"Phosphorylation-dependent recognition by AP-1 adaptors not demonstrated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the kinase phosphorylating the MBD3–MBD4 linker, the structural basis for copper release into the TGN/vesicle lumen, reconciliation of lysosomal exocytosis versus transcytosis models of hepatic copper excretion, and whether ATP7B dimerization is required for transport activity.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Kinase identity unknown\", \"Luminal copper release mechanism not structurally resolved\", \"Lysosomal exocytosis vs. transcytosis debate unresolved\", \"Functional role of dimerization untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 1, 3, 8, 14]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [3, 4, 14, 18]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [4, 7, 8, 10, 11]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [11, 19, 20]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [2, 10, 21, 32]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [23, 24]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [3, 4, 14, 18]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 8, 23, 24]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [4, 26, 32]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [8, 23, 24]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [5, 6, 20]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"COMMD1\",\n      \"CLU\",\n      \"HSPA1A\",\n      \"ATOX1\",\n      \"MAP1LC3B\",\n      \"AP1M1\",\n      \"GLRX\",\n      \"DCTN4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}